{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:07:38Z","timestamp":1788977258281,"version":"build-2803163510"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Region V\u00e4sterbotten","award":["RV-1035313, RV-1010683"],"award-info":[{"award-number":["RV-1035313, RV-1010683"]}]},{"name":"Norrlandska Hj\u00e4rtfonden"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Hypertrophic cardiomyopathy (HCM) is a genetic heart disease characterized by left ventricular hypertrophy. Mutations in genes for sarcomere proteins, e.g., in cardiac myosin-binding protein C (cMyBPC), may cause symptoms like heart failure and sudden cardiac death. In HCM, the heart utilizes high amounts of glucose. Increased glucose metabolism creates intermediates for hyaluronan (HA) synthesis, resulting in HA accumulation within the extracellular space, which could contribute to cardiomyocyte hypertrophy. We aimed to describe the connection between HA and cardiomyocyte hypertrophy using cMyBPC\n                    <jats:sup>+\/-<\/jats:sup>\n                    mice treated with two different \u03b2-blockers \u2013 either metoprolol or propranolol \u2013 for 11 months. The results showed that HA metabolism is altered in HCM, and that HA is significantly more abundant in hearts of cMyBPC\n                    <jats:sup>+\/-<\/jats:sup>\n                    mice compared to wild-type mice. Areas of high HA abundance were spread around the tissue in a \u2018patchy\u2019 manner. This focally increased HA concentration correlated with increased cardiomyocyte size in the same areas of the heart. Gene expression of HA synthase 2 was elevated in cMyBPC\n                    <jats:sup>+\/-<\/jats:sup>\n                    mice. Treatment with propranolol maintained HA synthase 2 at wild-type level, while significantly increasing HA synthase 3 expression. However, treatment with metoprolol or propranolol did not prevent HA accumulation nor decreased cardiomyocyte hypertrophy. These novel findings visualise a spatial connection between high HA abundance and cardiomyocyte hypertrophy in the hearts of cMyBPC\n                    <jats:sup>+\/-<\/jats:sup>\n                    mice.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0342635","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:29:01Z","timestamp":1788974941000},"page":"e0342635","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiomyocyte hypertrophy co-localizes with accumulation of hyaluronan in cMyBPC+\/- mice hearts"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0996-2476","authenticated-orcid":true,"given":"Anna","family":"Strnadov\u00e1","sequence":"first","affiliation":[{"name":"Ume\u00e5 University","place":["Ume\u00e5, Sweden"],"department":["Department of Public Health and Clinical Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8632-4502","authenticated-orcid":true,"given":"Madelene","family":"Ericsson","sequence":"additional","affiliation":[{"name":"Pathology, Ume\u00e5 University","place":["Ume\u00e5, Sweden"],"department":["Department of Medical Biosciences"]},{"name":"Ume\u00e5 Centre for Molecular Medicine, Ume\u00e5 University","place":["Ume\u00e5, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3957-6066","authenticated-orcid":true,"given":"Rakel","family":"Nyr\u00e9n","sequence":"additional","affiliation":[{"name":"Pathology, Ume\u00e5 University","place":["Ume\u00e5, Sweden"],"department":["Department of Medical Biosciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Dudka","sequence":"additional","affiliation":[{"name":"Ume\u00e5 University","place":["Ume\u00e5, Sweden"],"department":["Department of Chemistry"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stellan","family":"M\u00f6rner","sequence":"additional","affiliation":[{"name":"Ume\u00e5 University","place":["Ume\u00e5, Sweden"],"department":["Department of Public Health and Clinical Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3822-0725","authenticated-orcid":true,"given":"Urban","family":"Hellman","sequence":"additional","affiliation":[{"name":"Ume\u00e5 University","place":["Ume\u00e5, Sweden"],"department":["Department of Public Health and Clinical Medicine"]},{"name":"Ume\u00e5 University","place":["Ume\u00e5, Sweden"],"department":["Department of Clinical Microbiology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"12","key":"pone.0342635.ref001","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/biom9120878","article-title":"Hypertrophic cardiomyopathy: an overview of genetics and management","volume":"9","author":"P Teekakirikul","year":"2019","journal-title":"Biomolecules"},{"issue":"23","key":"pone.0342635.ref002","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"149","author":"SR Ommen","year":"2024","journal-title":"Circulation"},{"issue":"19","key":"pone.0342635.ref003","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1038\/s44318-024-00199-x","article-title":"Reassessing the unifying hypothesis for hypercontractility caused by myosin mutations in hypertrophic cardiomyopathy","volume":"43","author":"JA Spudich","year":"2024","journal-title":"EMBO J"},{"key":"pone.0342635.ref004","article-title":"The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy","author":"MS Maron","year":"2024","journal-title":"Am J Cardiol"},{"issue":"2","key":"pone.0342635.ref005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/medicina57020168","article-title":"Sudden Cardiac Death in Athletes: From the Basics to the Practical Work-Up","volume":"57","author":"AN Kochi","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"pone.0342635.ref006","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s44348-025-00050-9","article-title":"Current and emerging medical and surgical therapy in hypertrophic cardiomyopathy","volume":"33","author":"KA Kim","year":"2025","journal-title":"J Cardiovasc Imaging"},{"issue":"8","key":"pone.0342635.ref007","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010687","article-title":"Targeted Therapies in Pediatric and Adult Patients With Hypertrophic Heart Disease: From Molecular Pathophysiology to Personalized Medicine","volume":"16","author":"E Monda","year":"2023","journal-title":"Circ Heart Fail"},{"issue":"2","key":"pone.0342635.ref008","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1574887109666140908125158","article-title":"Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies","volume":"9","author":"I \u00d6stman-Smith","year":"2014","journal-title":"Rev Recent Clin Trials"},{"issue":"8","key":"pone.0342635.ref009","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s00246-015-1250-1","article-title":"Intrauterine Treatment of a Fetus with Familial Hypertrophic Cardiomyopathy Secondary to MYH7 Mutation","volume":"36","author":"MG Hill","year":"2015","journal-title":"Pediatr Cardiol"},{"issue":"6273","key":"pone.0342635.ref010","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"EM Green","year":"2016","journal-title":"Science"},{"issue":"5","key":"pone.0342635.ref011","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/heart.84.5.476","article-title":"Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease","volume":"84","author":"AM Varnava","year":"2000","journal-title":"Heart"},{"issue":"5","key":"pone.0342635.ref012","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0168-9525(03)00081-7","article-title":"Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion","volume":"19","author":"H Ashrafian","year":"2003","journal-title":"Trends Genet"},{"issue":"21","key":"pone.0342635.ref013","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","article-title":"Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy","volume":"144","author":"S Ranjbarvaziri","year":"2021","journal-title":"Circulation"},{"issue":"13","key":"pone.0342635.ref014","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/1873-3468.13496","article-title":"Energetic drain driving hypertrophic cardiomyopathy","volume":"593","author":"V Sequeira","year":"2019","journal-title":"FEBS Lett"},{"key":"pone.0342635.ref015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.2009.05100.x","article-title":"Return to the fetal gene program: a suggested metabolic link to gene expression in the heart","volume":"1188","author":"H Taegtmeyer","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"pone.0342635.ref016","unstructured":"Gasser S, Roessl U, Holzwart E, Ablasser K, Friehs I, M\u00e4chler H, et al. Shift from adult to fetal metabolic phenotype during prolonged experimental myocardial ischemia: A study on the effect of beta blockers upon gene expression of transmembrane glucose transporters."},{"issue":"3","key":"pone.0342635.ref017","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"WC Stanley","year":"2005","journal-title":"Physiol Rev"},{"issue":"4","key":"pone.0342635.ref018","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000369782","article-title":"Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis","volume":"130","author":"BK Kundu","year":"2015","journal-title":"Cardiology"},{"key":"pone.0342635.ref019","article-title":"Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts","volume":"267","author":"MF Allard","year":"1994","journal-title":"Am J Physiol"},{"key":"pone.0342635.ref020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1302.017","article-title":"Linking gene expression to function: metabolic flexibility in the normal and diseased heart","volume":"1015","author":"H Taegtmeyer","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"pone.0342635.ref021","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.nuclcard.2006.01.021","article-title":"Hypertensive left ventricular hypertrophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency","volume":"13","author":"L de las Fuentes","year":"2006","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"pone.0342635.ref022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ygeno.2010.04.003","article-title":"Temporal correlation between transcriptional changes and increased synthesis of hyaluronan in experimental cardiac hypertrophy","volume":"96","author":"U Hellman","year":"2010","journal-title":"Genomics"},{"issue":"1","key":"pone.0342635.ref023","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1369\/0022155420929772","article-title":"Cell energy metabolism and hyaluronan synthesis","volume":"69","author":"I Caon","year":"2021","journal-title":"J Histochem Cytochem"},{"issue":"8","key":"pone.0342635.ref024","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.4239\/wjd.v12.i8.1233","article-title":"Cardiac changes in infants of diabetic mothers","volume":"12","author":"M Al-Biltagi","year":"2021","journal-title":"World J Diabetes"},{"issue":"1","key":"pone.0342635.ref025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00441-007-0562-8","article-title":"Parallel up-regulation of FGF-2 and hyaluronan during development of cardiac hypertrophy in rat","volume":"332","author":"U Hellman","year":"2008","journal-title":"Cell Tissue Res"},{"issue":"12","key":"pone.0342635.ref026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014393","article-title":"Growth factor PDGF-BB stimulates cultured cardiomyocytes to synthesize the extracellular matrix component hyaluronan","volume":"5","author":"U Hellman","year":"2010","journal-title":"PLoS One"},{"key":"pone.0342635.ref027","doi-asserted-by":"crossref","first-page":"545219","DOI":"10.1155\/2012\/545219","article-title":"Hyaluronan and collagen in human hypertrophic cardiomyopathy: a morphological analysis","volume":"2012","author":"M Hellstr\u00f6m","year":"2012","journal-title":"Cardiol Res Pract"},{"issue":"2","key":"pone.0342635.ref028","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/cells8020097","article-title":"Low Molecular Mass Myocardial Hyaluronan in Human Hypertrophic Cardiomyopathy","volume":"8","author":"CE Lor\u00e9n","year":"2019","journal-title":"Cells"},{"issue":"8","key":"pone.0342635.ref029","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1074\/jbc.M112.443879","article-title":"Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3","volume":"288","author":"K Rilla","year":"2013","journal-title":"J Biol Chem"},{"key":"pone.0342635.ref030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.matbio.2017.12.015","article-title":"UDP-sugar accumulation drives hyaluronan synthesis in breast cancer","volume":"67","author":"S Oikari","year":"2018","journal-title":"Matrix Biology"},{"issue":"15","key":"pone.0342635.ref031","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1111\/febs.14777","article-title":"Hyaluronan: molecular size-dependent signaling and biological functions in inflammation and cancer","volume":"286","author":"AG Tavianatou","year":"2019","journal-title":"FEBS J"},{"key":"pone.0342635.ref032","doi-asserted-by":"crossref","first-page":"563818","DOI":"10.1155\/2015\/563818","article-title":"Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology","volume":"2015","author":"JM Cyphert","year":"2015","journal-title":"Int J Cell Biol"},{"issue":"3","key":"pone.0342635.ref033","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1185\/03007990903533681","article-title":"Effects of beta-blockers on glucose and lipid metabolism","volume":"26","author":"VA Fonseca","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"pone.0342635.ref034","doi-asserted-by":"crossref","first-page":"115922","DOI":"10.1016\/j.bcp.2023.115922","article-title":"Effects of propranolol on glucose metabolism in hemangioma-derived endothelial cells","volume":"218","author":"K Yang","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"pone.0342635.ref035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cardiores.2004.04.009","article-title":"Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice","volume":"63","author":"L Carrier","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"14","key":"pone.0342635.ref036","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/heartjnl-2011-300531","article-title":"Hypertrophic cardiomyopathy in children","volume":"98","author":"JP Moak","year":"2012","journal-title":"Heart"},{"issue":"5","key":"pone.0342635.ref037","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s10741-020-09931-1","article-title":"Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging","volume":"26","author":"ID Muresan","year":"2021","journal-title":"Heart Fail Rev"},{"issue":"11","key":"pone.0342635.ref038","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.00309.2015","article-title":"Cardiac hypertrophy and decreased high-density lipoprotein cholesterol in Lrig3-deficient mice","volume":"310","author":"M Hellstr\u00f6m","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"pone.0342635.ref039","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1258\/la.2010.010094","article-title":"A comparison of retrospectively self-gated magnetic resonance imaging and high-frequency echocardiography for characterization of left ventricular function in mice","volume":"45","author":"BH Amundsen","year":"2011","journal-title":"Lab Anim"},{"key":"pone.0342635.ref040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-4939-8935-5_22","article-title":"Making formalin-fixed, paraffin embedded blocks.","author":"A Sadeghipour","year":"2019","journal-title":"Biobanking: Methods and Protocols"},{"issue":"1","key":"pone.0342635.ref041","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s42003-021-02837-0","article-title":"AMPK activator O304 improves metabolic and cardiac function, and exercise capacity in aged mice","volume":"4","author":"M Ericsson","year":"2021","journal-title":"Commun Biol"},{"issue":"8","key":"pone.0342635.ref042","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1111\/bcp.14754","article-title":"Beta-blocker-associated hypoglycaemia: New insights from a real-world pharmacovigilance study","volume":"87","author":"C Carnovale","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"pone.0342635.ref043","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacbts.2024.10.017","article-title":"Experimental Models of Hypertrophic Cardiomyopathy: A Systematic Review. JACC:","volume":"10","author":"FW van den Dolder","year":"2025","journal-title":"Basic to Translational Science"},{"issue":"11","key":"pone.0342635.ref044","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3390\/biom10111525","article-title":"Hyaluronan: Metabolism and Function","volume":"10","author":"T Kobayashi","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"pone.0342635.ref045","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00130.2022","article-title":"Mechanisms of coordinating hyaluronan and glycosaminoglycan production by nucleotide sugars","volume":"322","author":"BM Zimmer","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"issue":"10","key":"pone.0342635.ref046","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1080\/17425255.2020.1803279","article-title":"Pharmacogenetic factors affecting \u03b2-blocker metabolism and response","volume":"16","author":"CD Thomas","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"pone.0342635.ref047","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/15216540214929","article-title":"Mammalian hyaluronan synthases","volume":"54","author":"N Itano","year":"2002","journal-title":"IUBMB Life"},{"issue":"4","key":"pone.0342635.ref048","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1536\/ihj.21.563","volume":"21","author":"K Takeda","year":"1980","journal-title":"Japanese Heart Journal"},{"issue":"1","key":"pone.0342635.ref049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4081\/cardiogenetics.2012.e5","article-title":"Transcriptional Regulation of Cardiac Genes Balance Pro- and Anti-Hypertrophic Mechanisms in Hypertrophic Cardiomyopathy","volume":"2","author":"N Genneb\u00e4ck","year":"2012","journal-title":"Cardiogenetics"},{"issue":"6","key":"pone.0342635.ref050","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1165\/rcmb.2012-0101OC","article-title":"Steroids and \u03b22-agonists regulate hyaluronan metabolism in asthmatic airway smooth muscle cells","volume":"47","author":"E Papakonstantinou","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"pone.0342635.ref051","doi-asserted-by":"crossref","first-page":"104826","DOI":"10.1016\/j.jbc.2023.104826","article-title":"Human TMEM2 is not a catalytic hyaluronidase, but a regulator of hyaluronan metabolism via HYBID (KIAA1199\/CEMIP) and HAS2 expression","volume":"299","author":"S Sato","year":"2023","journal-title":"J Biol Chem"},{"issue":"18","key":"pone.0342635.ref052","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1074\/jbc.M116.770149","article-title":"A mammalian homolog of the zebrafish transmembrane protein 2 (TMEM2) is the long-sought-after cell-surface hyaluronidase","volume":"292","author":"H Yamamoto","year":"2017","journal-title":"J Biol Chem"},{"key":"pone.0342635.ref053","doi-asserted-by":"crossref","first-page":"1222425","DOI":"10.3389\/fimmu.2023.1222425","article-title":"Research on the biological mechanism and potential application of CEMIP","volume":"14","author":"Y Liu","year":"2023","journal-title":"Front Immunol"},{"issue":"8","key":"pone.0342635.ref054","doi-asserted-by":"crossref","first-page":"167473","DOI":"10.1016\/j.bbadis.2024.167473","article-title":"KIAA1199\/CEMIP knockdown attenuates cardiac remodeling post myocardial infarction by activating TSP4 pathway in mice","volume":"1870","author":"Y Zha","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"pone.0342635.ref055","first-page":"638","article-title":"Characterizing adrenergic regulation of glucose transporter 4-mediated glucose uptake and metabolism in the heart","volume":"8","author":"A Jovanovic","year":"2023","journal-title":"JACC: Basic to Translational Science"},{"issue":"6","key":"pone.0342635.ref056","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-2004-820915","article-title":"Effects of moxonidine vs. metoprolol on blood pressure and metabolic control in hypertensive subjects with type 2 diabetes","volume":"112","author":"S Jacob","year":"2004","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"pone.0342635.ref057","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.RES.0000012222.70819.64","article-title":"Hypertrophic Cardiomyopathy in Cardiac Myosin Binding Protein-C Knockout Mice","volume":"90","author":"SP Harris","year":"2002","journal-title":"Circulation Research"},{"issue":"4","key":"pone.0342635.ref058","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/01.RES.88.4.383","article-title":"Comparison of two murine models of familial hypertrophic cardiomyopathy","volume":"88","author":"BK McConnell","year":"2001","journal-title":"Circ Res"},{"issue":"9","key":"pone.0342635.ref059","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1172\/JCI7377","article-title":"Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice","volume":"104","author":"BK McConnell","year":"1999","journal-title":"J Clin Invest"},{"issue":"12","key":"pone.0342635.ref060","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1113\/JP274134","article-title":"The impact of age and frailty on ventricular structure and function in C57BL\/6J mice","volume":"595","author":"HA Feridooni","year":"2017","journal-title":"J Physiol"},{"issue":"11","key":"pone.0342635.ref061","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","article-title":"Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction","volume":"119","author":"SJ van Dijk","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"pone.0342635.ref062","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00424-018-2226-9","article-title":"Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy","volume":"471","author":"AA Glazier","year":"2019","journal-title":"Pflugers Arch"},{"issue":"21","key":"pone.0342635.ref063","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1161\/CIRCULATIONAHA.107.706523","article-title":"Control of in vivo contraction\/relaxation kinetics by myosin binding protein C","volume":"116","author":"T Nagayama","year":"2007","journal-title":"Circulation"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:29:11Z","timestamp":1788974951000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0342635"}},"subtitle":[],"editor":[{"given":"Andre","family":"van Wijnen","sequence":"first","affiliation":[{"name":"University of Vermont College of Medicine","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":63,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0342635","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}